These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes. Plum J, Lordnejad MR, Grabensee B. Kidney Int; 1998 Jul; 54(1):224-35. PubMed ID: 9648083 [Abstract] [Full Text] [Related]
3. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study. Plum J, Erren C, Fieseler C, Kirchgessner J, Passlick-Deetjen J, Grabensee B. Perit Dial Int; 1999 Jul; 19(5):418-28. PubMed ID: 11379854 [Abstract] [Full Text] [Related]
4. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations. Plum J, Fusshöller A, Schoenicke G, Busch T, Erren C, Fieseler C, Kirchgessner J, Passlick-Deetjen J, Grabensee B. Nephrol Dial Transplant; 1997 Aug; 12(8):1652-60. PubMed ID: 9269644 [Abstract] [Full Text] [Related]
5. Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells. Plum J, Razeghi P, Lordnejad RM, Perniok A, Fleisch M, Fusshöller A, Schneider M, Grabensee B. Am J Kidney Dis; 2001 Oct; 38(4):867-75. PubMed ID: 11576893 [Abstract] [Full Text] [Related]
6. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro. Sundaram S, Cendoroglo M, Cooker LA, Jaber BL, Faict D, Holmes CJ, Pereira BJ. Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184 [Abstract] [Full Text] [Related]
7. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid. Liberek T, Lichodziejewska-Niemierko M, Knopinska-Posluszny W, Schaub TP, Kirchgessner J, Passlick-Deetjen J, Rutkowski B. Perit Dial Int; 2002 Nov; 22(6):663-9. PubMed ID: 12556067 [Abstract] [Full Text] [Related]
8. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid. Skoufos L, Topley N, Cooker L, Dawnay A, Millar DJ, Holmes CJ, Faict D. Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882 [Abstract] [Full Text] [Related]
9. Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system. Fusshoeller A, Baehr J, Grabensee B, Plum J. Perit Dial Int; 2005 Dec; 25(4):387-93. PubMed ID: 16022097 [Abstract] [Full Text] [Related]
10. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Fusshoeller A, Plail M, Grabensee B, Plum J. Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322 [Abstract] [Full Text] [Related]
11. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991]. Nau B, Schmitt CP, Almeida M, Arbeiter K, Ardissino G, Bonzel KE, Edefonti A, Fischbach M, Haluany K, Misselwitz J, Kemper MJ, Rönnholm K, Wygoda S, Schaefer F, European Pediatric Peritoneal Dialysis Study Group. BMC Nephrol; 2004 Oct 14; 5():14. PubMed ID: 15485574 [Abstract] [Full Text] [Related]
12. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats. Pawlaczyk K, Kuzlan-Pawlaczyk M, Wieczorowska-Tobis K, Polubinska A, Wisniewska J, Faict D, Holmes CJ, Breborowicz A. Perit Dial Int; 1999 Oct 14; 19 Suppl 2():S370-7. PubMed ID: 10406549 [Abstract] [Full Text] [Related]
13. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion. MacKenzie RK, Holmes CJ, Moseley A, Jenkins JP, Williams JD, Coles GA, Faict D, Topley N. J Am Soc Nephrol; 1998 Aug 14; 9(8):1499-506. PubMed ID: 9697673 [Abstract] [Full Text] [Related]
14. In vitro biocompatibility evaluation of a novel bicarbonate-buffered amino-acid solution for peritoneal dialysis. Jörres A, Gahl GM, Ludat K, Frei U, Passlick-Deetjen J. Nephrol Dial Transplant; 1997 Mar 14; 12(3):543-9. PubMed ID: 9075138 [Abstract] [Full Text] [Related]
15. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. Topley N, Kaur D, Petersen MM, Jörres A, Williams JD, Faict D, Holmes CJ. J Am Soc Nephrol; 1996 Feb 14; 7(2):218-24. PubMed ID: 8785390 [Abstract] [Full Text] [Related]
16. In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions. Jörres A, Gahl GM, Topley N, Neubauer A, Ludat K, Müller C, Passlick-Deetjen J. Nephrol Dial Transplant; 1994 Feb 14; 9(7):785-90. PubMed ID: 7970120 [Abstract] [Full Text] [Related]
17. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Witowski J, Topley N, Jörres A, Liberek T, Coles GA, Williams JD. Kidney Int; 1995 Jan 14; 47(1):282-93. PubMed ID: 7731159 [Abstract] [Full Text] [Related]
18. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Mortier S, Faict D, Schalkwijk CG, Lameire NH, De Vriese AS. Kidney Int; 2004 Sep 14; 66(3):1257-65. PubMed ID: 15327425 [Abstract] [Full Text] [Related]